<p>National HealthCare (NHC) 刚刚公布了第三季度业绩，强调收入增长但净收入相比去年有所下降。除了财报外，公司还重申了对股东的季度分红。</p>
<p>查看我们对 National HealthCare 的最新分析。</p>
<p>National HealthCare 的股价在近期表现出令人印象深刻的短期动能，在过去 90 天内上涨了近 27%，尽管其一年期的总股东回报仍略显负面。近期的财报和持续的分红记录无疑吸引了市场的关注，暗示长期的乐观情绪正在回归。</p>
<p>如果强劲的分红历史引起了你的兴趣，你可能想看看该行业还有什么其他动态。探索完整列表，免费查看。</p>
<p>随着近期股价的急剧反弹，投资者需要权衡 National HealthCare 是否仍然以有吸引力的价值交易，或者近期的表现是否意味着市场现在已经完全定价未来的增长潜力。</p>
<h2>最受欢迎的叙述：29% 被低估</h2>
<p>根据 DanielGC 的分析，目前的股价远低于他们计算的公允价值，暗示如果关键假设成立，可能会出现可观的机会。股票当前交易价格与这一更大胆目标之间的差距，为那些超越最新业绩的投资者提供了一个引人注目的故事。</p>
<blockquote>
<p><em>这一叙述探讨了市场因短期问题而错误定价 NHC 的观点，创造了一个有吸引力的入场点。我们假设公司将恢复其净收入，市场将重新评估其估值。</em></p>
</blockquote>
<p>阅读完整叙述。</p>
<p>好奇哪些变量可能迅速提升 NHC 的估值？这一公允价值背后的关键驱动因素绝非普通。发现哪些备受期待的财务里程碑和市场重新定价可能将今天的价格转变为引人注目的价值。想了解背后的数学故事吗？继续阅读，看看什么可能会让你感到惊讶。</p>
<p><strong>结果：公允价值为 179.80 美元（被低估）</strong></p>
<p>完整阅读叙述，了解预测背后的原因。</p>
<p>然而，利润率的持续下降或收购整合的困难可能会挑战投资者所期待的重新估值故事。</p>
<p>了解 National HealthCare 叙述的关键风险。</p>
<h2>另一种观点：DCF 视角</h2>
<p>虽然基于倍数的估值将 National HealthCare 视为被低估，但我们的 DCF 模型表明市场可能忽视了一个更大的差距。根据 SWS DCF 模型，NHC 的股票交易价格远低于其公允价值。这是否意味着更深层次的机会，还是仅仅显示出对公允价值的看法差异如此之大？</p>
<p>深入了解 SWS DCF 模型如何得出其公允价值。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf"/></p>
<p>截至 2025 年 11 月的 NHC 折现现金流</p>
<h2>构建你自己的 National HealthCare 叙述</h2>
<p>如果你有自己的观点或喜欢亲自深入数字，构建个人叙述只需几分钟，何不按照自己的方式来呢？</p>
<p>你进行 National HealthCare 研究的一个很好的起点是我们的分析，强调了 2 个关键奖励和 1 个重要警示信号，这可能会影响你的投资决策。</p>
<h2>寻找更多投资想法？</h2>
<p>聪明的投资者不会在场边等待下一个大事件。利用以下精心挑选的筛选器，抓住符合你目标的新机会。</p>
<ul>
<li>通过查看这些 870 只基于现金流的被低估股票，发现潜在的市场错误定价。在这里，你会找到基于强劲现金流基本面的公司。</li>
<li>通过瞄准这些收益率超过 3% 的 16 只分红股票，最大化你的收入追求，这些股票提供可靠的收益率，并且历史上分红稳定。</li>
<li>通过这些 24 只 AI 便士股票，进入快速发展的人工智能世界，提前发现新兴技术领导者。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

National医疗

<p>National 医疗（NHC）在第三季度报告了更高的收入但净收入下降，重申了其季度股息。尽管过去 90 天股价上涨近 27%，但一年期回报略显负面。分析师认为 NHC 被低估，公允价值估计为 179.80 美元，显示出潜在的增长空间。然而，利润率下降和收购挑战等风险可能会影响这一前景。折现现金流模型（DCF）也表明显著低估，突显了对公允价值的不同看法。文章强调在做出投资决策之前进行全面分析的重要性</p>

<p>National HealthCare (NHC) just reported its third quarter results, highlighting higher revenue but a dip in net income compared to last year. Along with its earnings, the company also reaffirmed its quarterly dividend for shareholders.</p>
<div class="lb-trans"><p>National HealthCare (NHC) 刚刚公布了第三季度业绩，强调收入增长但净收入相比去年有所下降。除了财报外，公司还重申了对股东的季度分红。</p>
</div><p>See our latest analysis for National HealthCare.</p>
<div class="lb-trans"><p>查看我们对 National HealthCare 的最新分析。</p>
</div><p>National HealthCare’s share price has shown impressive near-term momentum, climbing almost 27% over the past 90 days, even as its one-year total shareholder return remains slightly negative. Recent earnings and its consistent dividend track record have certainly caught the market’s attention, hinting at renewed optimism for the long term.</p>
<div class="lb-trans"><p>National HealthCare 的股价在近期表现出令人印象深刻的短期动能，在过去 90 天内上涨了近 27%，尽管其一年期的总股东回报仍略显负面。近期的财报和持续的分红记录无疑吸引了市场的关注，暗示长期的乐观情绪正在回归。</p>
</div><p>If strong dividend histories pique your interest, you might want to see what else is happening in the sector. Explore See the full list for free..</p>
<div class="lb-trans"><p>如果强劲的分红历史引起了你的兴趣，你可能想看看该行业还有什么其他动态。探索完整列表，免费查看。</p>
</div><p>With shares rebounding sharply in recent months, investors are left to weigh whether National HealthCare is still trading at an attractive value, or if recent performance means the market is now fully pricing in future growth potential.</p>
<div class="lb-trans"><p>随着近期股价的急剧反弹，投资者需要权衡 National HealthCare 是否仍然以有吸引力的价值交易，或者近期的表现是否意味着市场现在已经完全定价未来的增长潜力。</p>
</div><h2>Most Popular Narrative: 29% Undervalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：29% 被低估</h2>
</div><p>According to DanielGC, the current share price is well below their calculated fair value, hinting at what could be a substantial opportunity if key assumptions play out. The gap between where the stock trades today and this bolder target sets up a compelling story for investors who look beyond the latest results.</p>
<div class="lb-trans"><p>根据 DanielGC 的分析，目前的股价远低于他们计算的公允价值，暗示如果关键假设成立，可能会出现可观的机会。股票当前交易价格与这一更大胆目标之间的差距，为那些超越最新业绩的投资者提供了一个引人注目的故事。</p>
</div><blockquote>
<p><em>This narrative explores the perspective that the market is mispricing NHC due to a short-term issue, creating an attractive entry point. We assume the company will recover its net income and the market will re-rate its valuation.</em></p>
</blockquote>
<div class="lb-trans"><blockquote>
<p><em>这一叙述探讨了市场因短期问题而错误定价 NHC 的观点，创造了一个有吸引力的入场点。我们假设公司将恢复其净收入，市场将重新评估其估值。</em></p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整叙述。</p>
</div><p>Curious which variables could ramp up NHC’s valuation fast? The key drivers behind this fair value are far from ordinary. Discover which much-anticipated financial milestones and market reratings could transform today’s price into a value that turns heads. Want the full story behind the math? Read on and see what might surprise you most.</p>
<div class="lb-trans"><p>好奇哪些变量可能迅速提升 NHC 的估值？这一公允价值背后的关键驱动因素绝非普通。发现哪些备受期待的财务里程碑和市场重新定价可能将今天的价格转变为引人注目的价值。想了解背后的数学故事吗？继续阅读，看看什么可能会让你感到惊讶。</p>
</div><p><strong>Result: Fair Value of $179.80 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为 179.80 美元（被低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的原因。</p>
</div><p>However, a sustained drop in margins or tougher integration of acquisitions could challenge the revaluation story that investors are hoping for.</p>
<div class="lb-trans"><p>然而，利润率的持续下降或收购整合的困难可能会挑战投资者所期待的重新估值故事。</p>
</div><p>Find out about the key risks to this National HealthCare narrative.</p>
<div class="lb-trans"><p>了解 National HealthCare 叙述的关键风险。</p>
</div><h2>Another View: The DCF Perspective</h2>
<div class="lb-trans"><h2>另一种观点：DCF 视角</h2>
</div><p>While the multiples-based valuation presents National HealthCare as undervalued, our DCF model indicates the market might be overlooking an even larger gap. According to the SWS DCF model, NHC's shares are trading well below their fair value. Could this signal a deeper opportunity, or does it show just how widely opinions on fair value can differ?</p>
<div class="lb-trans"><p>虽然基于倍数的估值将 National HealthCare 视为被低估，但我们的 DCF 模型表明市场可能忽视了一个更大的差距。根据 SWS DCF 模型，NHC 的股票交易价格远低于其公允价值。这是否意味着更深层次的机会，还是仅仅显示出对公允价值的看法差异如此之大？</p>
</div><p>Look into how the SWS DCF model arrives at its fair value.</p>
<div class="lb-trans"><p>深入了解 SWS DCF 模型如何得出其公允价值。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf" alt="" original-src="https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf"/></p>
<p>NHC Discounted Cash Flow as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 NHC 折现现金流</p>
</div><h2>Build Your Own National HealthCare Narrative</h2>
<div class="lb-trans"><h2>构建你自己的 National HealthCare 叙述</h2>
</div><p>If you’ve got your own perspective or like diving into the numbers firsthand, crafting a personal narrative takes just a few minutes, so why not Do it your way?</p>
<div class="lb-trans"><p>如果你有自己的观点或喜欢亲自深入数字，构建个人叙述只需几分钟，何不按照自己的方式来呢？</p>
</div><p>A great starting point for your National HealthCare research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.</p>
<div class="lb-trans"><p>你进行 National HealthCare 研究的一个很好的起点是我们的分析，强调了 2 个关键奖励和 1 个重要警示信号，这可能会影响你的投资决策。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>Smart investors don’t wait on the sidelines for the next big thing. Seize new opportunities that match your goals using these handpicked screens below.</p>
<div class="lb-trans"><p>聪明的投资者不会在场边等待下一个大事件。利用以下精心挑选的筛选器，抓住符合你目标的新机会。</p>
</div><ul>
<li>Uncover potential market mispricings by checking out these 870 undervalued stocks based on cash flows. Here, you’ll find companies that stand out based on strong cash flow fundamentals.</li>
<li>Maximize your pursuit of income by targeting these 16 dividend stocks with yields &gt; 3%, which offers reliable yields above 3% and historically consistent payouts.</li>
<li>Tap into the surging world of artificial intelligence with these 24 AI penny stocks to spot emerging technology leaders before others catch on.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过查看这些 870 只基于现金流的被低估股票，发现潜在的市场错误定价。在这里，你会找到基于强劲现金流基本面的公司。</li>
<li>通过瞄准这些收益率超过 3% 的 16 只分红股票，最大化你的收入追求，这些股票提供可靠的收益率，并且历史上分红稳定。</li>
<li>通过这些 24 只 AI 便士股票，进入快速发展的人工智能世界，提前发现新兴技术领导者。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

探讨 National Healthcare (NHC) 在第三季度业绩公布后的估值及其持续的股息承诺